Chemomab Therapeutics Ltd DRC Long-term Investment Intensity
Chemomab Therapeutics Ltd DRC long-term investment intensity. Chemomab Therapeutics Ltd DRC (CMMB) has a Long-term Investment Intensity of 0.0% as of March 2021. Long-term investments of $4.00K represent 0.0% of total assets of $60.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read CMMB current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Chemomab Therapeutics Ltd DRC (2020–2020)
Long-term investment intensity of Chemomab Therapeutics Ltd DRC from 2020 to 2020. This chart shows how Chemomab Therapeutics Ltd DRC's Long-term Investment Intensity has evolved across 1 annual periods from 2020 to 2020. As of March 2021, the intensity stands at 0.0%, reflecting long-term investments of $4.00K against total assets of $60.12 Million USD.
Chemomab Therapeutics Ltd DRC Long-term Investment Intensity by Year (2020–2020)
Chemomab Therapeutics Ltd DRC long-term investment intensity by year from 2020 to 2020. The table below presents the year-by-year Long-term Investment Intensity for Chemomab Therapeutics Ltd DRC from 2020 to 2020, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CMMB asset base.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.0% | $4.00K | $12.48 Million | — |